Evidence map›Paper›PMID 31682174›Full record

ArticleAmerican journal of physiology. Renal physiology2020

Dietary phosphate restriction attenuates polycystic kidney disease in mice.

Faith Omede, Shiqin Zhang, Cassandra Johnson, Emily Daniel, Yan Zhang, Timothy A Fields, Joseph Boulanger, Shiguang Liu, Ishfaq Ahmed, Shahid Umar and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. The effects of elevated phosphate on the kidney - damaging the gatekeeper.Pflugers Archiv : European journal of physiology · 2026
    Review
  3. Renal Tubule-Specific Deletion of Nephrocystin 3International journal of molecular sciences · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Kidney stone formation in a novel murine model of polycystic kidney disease.American journal of physiology. Renal physiology · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Faith OmedeThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Shiqin ZhangThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Cassandra JohnsonThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Emily DanielThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Yan ZhangThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Timothy A FieldsThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Joseph BoulangerSanofi Genzyme, Cambridge, Massachusetts.
Shiguang LiuSanofi Genzyme, Cambridge, Massachusetts.
Ishfaq AhmedDepartment of Surgery, University of Kansas Medical Center, Kansas City, Kansas.
Shahid UmarDepartment of Surgery, University of Kansas Medical Center, Kansas City, Kansas.
Darren Paul WallaceThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.
Jason R StubbsThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas.ORCID 0000-0003-4580-5745
University of Kansas Medical Center · USSanofi (United States) · US

Funding

Pilot and Feasibility CoreP30DK106912 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CALVET, JAMES P · 2015 to 2019
$5.5M
Impact of Phosphaturia on Renal Osteopontin Production and PKD ProgressionR01DK122212 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Jason Stubbs, Kurt A Zimmerman · 2019 to 2026
$3.1M
NIDDK NIH HHS P30 DK106912NIDDK NIH HHS R01 DK122212
6 · The paper itself

Abstract

Studies in rodents with reduced nephron mass have suggested a strong positive correlation between dietary phosphate consumption and CKD progression. Prior work by our group demonstrated that dietary phosphate restriction can prevent tubular injury and microcyst formation in rodents with glomerulonephritis. Tubular injury and cystic dilation of tubules are key contributors to kidney function decline in polycystic kidney disease (PKD). Here, we determined whether dietary phosphate restriction slows renal cyst growth and fibrosis in a mouse model of PKD.

Indexed as

PhosphatesAnimalsDisease Models, AnimalDisease ProgressionFemaleKidneyKinesinsMaleMiceMice, KnockoutPolycystic Kidney DiseasesKinesinsnephrocystin-3, mousePhosphateschronic kidney diseasefibroblast growth factor 23fibrosisphosphatepolycystic kidney disease

Identifiers

PMID31682174
PMCPMC6985825
OpenAlexW2985339033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.